Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 2
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2328)
- Volume 20, 2024 (20)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 2, 2006
Cost-benefit analysis of influenza vaccination in a public healthcare unit
Giorgio L Colombo, Antonio Ferro, Marta Vinci, Maria Zordan, Giulio Serra
Therapeutics and Clinical Risk Management 2006, 2:219-226
Published Date: 15 June 2006
Treatment of pruritic diseases with topical calcineurin inhibitors
Sonja Ständer, Funda Schürmeyer-Horst, Thomas A Luger, Elke Weisshaar
Therapeutics and Clinical Risk Management 2006, 2:213-218
Published Date: 15 June 2006
Rituximab and its potential for the treatment of rheumatoid arthritis
Adam Bryant, John Moore
Therapeutics and Clinical Risk Management 2006, 2:207-212
Published Date: 15 June 2006
The management of glaucoma and intraocular hypertension: current approaches and recent advances
Robert J Noecker
Therapeutics and Clinical Risk Management 2006, 2:193-206
Published Date: 15 June 2006
The return of fixed combinations in psychiatry: fluoxetine and olanzapine combination
Richard C Shelton
Therapeutics and Clinical Risk Management 2006, 2:187-192
Published Date: 15 June 2006
Flexible dosing with Darbepoetin alfa for the treatment of chemotherapy-induced anemia
Isabelle Wauters, Karin Pat, Johan Vansteenkiste
Therapeutics and Clinical Risk Management 2006, 2:175-186
Published Date: 15 June 2006
A review of daptomycin for injection (Cubicin) in the treatment of complicated skin and skin structure infections
D Matthew Shoemaker, Jikerkhoun Simou, William E Roland
Therapeutics and Clinical Risk Management 2006, 2:169-174
Published Date: 15 June 2006
Oral mucositis induced by anticancer treatments: physiopathology and treatments
D’Hondt, Lionel, Lonchay, Christophe, André, Marc, Canon, Jean-Luc
Therapeutics and Clinical Risk Management 2006, 2:159-168
Published Date: 15 June 2006
Voriconazole in the management of nosocomial invasive fungal infections
Javier Pemán, Miguel Salavert, Emilia Cantón, Isidro Jarque, Eva Romá, et al
Therapeutics and Clinical Risk Management 2006, 2:129-158
Published Date: 15 June 2006
Editorial ||FREE PAPER||
Garry Walsh
Therapeutics and Clinical Risk Management 2006, 2:127-128
Published Date: 15 June 2006